Direct targeting of C9ORF72 repeat RNA with fluorinated antisense oligonucleotides
Nucleic Acids Research · 23.04.2026 · 54 (8)
DOI: 10.1093/nar/gkag343 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 25.04.2026. Verfasst von Halle M Barber und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, McGill University, Montreal, QC H3A 0B8, Canada. Hauptthemen laut MEDLINE: Oligonucleotides, Antisense, C9orf72 Protein, Fluorine, DNA Repeat Expansion. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union Marie Skłodowska-Curie Actions, CSIC, NIH HHS.
Abstract (Originalsprache)
Hexanucleotide repeat expansions in the C9ORF72 gene are the most common genetic cause of amyotrophic lateral sclerosis and frontotemporal dementia. These expansions give rise to pathogenic sense and antisense repeat RNAs that form nuclear foci and undergo repeat-associated non-AUG translation, producing dipeptide repeat proteins with cellular toxicity. Directly targeting the causative repeat RNAs with antisense oligonucleotides represents a promising therapeutic strategy. One barrier to further development is the propensity of this G-rich repeat-containing RNA target to form stable secondary structures, which may hinder efficient hybridization. In this study, we designed a panel of fluorine-modified ASOs that target the sense repeat expansions. We identified C-rich F-ASO gapmers that reduced translation from sense repeat RNAs in a cell-based reporter assay and lowered the RNA foci burden in patient-derived cells. Structural analyses in vitro revealed that the 2′F-RNA gapmer formed a stable hairpin structure. Our results demonstrate that structural properties of fluorine modifications can be leveraged for effective binding of repeat RNA and highlight the potential for F-ASOs to serve as therapeutic tools when targeting toxic repeat RNAs in C9ORF72-mediated FTD/ALS and other repeat expansion diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, McGill University, Montreal, QC H3A 0B8, Canada.
- Biochemistry and Molecular Biology, Wake Forest University School of Medicine, Winston-Salem, NC 27101, United States.
- Division of Biochemistry and Molecular Biology, Southern Illinois University School of Medicine, Carbondale, IL 62901, United States.
- Centre for Developmental Neurobiology, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London SE1 1UL, United Kingdom.
- Institute of Physiological Chemistry, University Medical Center Johannes Gutenberg University, Mainz 55128, Germany.
- MRC Centre for Neurodevelopmental Disorders, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London SE1 1UL, United Kingdom.
ORCID-Profile: Halle M Barber, Keith T Gagnon, Masad J Damha, Miguel Garavís
Förderung
- European Union Marie Skłodowska-Curie Actions
- CSIC
- NIH HHS
- Natural Sciences and Engineering Research Council of Canada
- Ministerio de Ciencia e Innovación
- ERA-NET Neuron
- Fonds de Recherche du Québec
- National Institutes of Health
Zitieren
APA
Barber, H. M., Parasrampuria, M. A., Jurado-Arjona, J., Gamir-Morralla, A., Berninger, B., González, C., Gagnon, K. T., Damha, M. J., & Garavís, M. (2026). Direct targeting of C9ORF72 repeat RNA with fluorinated antisense oligonucleotides. Nucleic Acids Research, 54(8). https://doi.org/10.1093/nar/gkag343
Vancouver
Barber HM, Parasrampuria MA, Jurado-Arjona J, Gamir-Morralla A, Berninger B, González C, et al. Direct targeting of C9ORF72 repeat RNA with fluorinated antisense oligonucleotides. Nucleic Acids Research. 2026;54(8). doi:10.1093/nar/gkag343
BibTeX
@article{Barber2026,
author = {Barber, Halle M and Parasrampuria, Mansi A and Jurado-Arjona, Jerónimo and Gamir-Morralla, Andrea and Berninger, Benedikt and González, Carlos and Gagnon, Keith T and Damha, Masad J and Garavís, Miguel},
title = {Direct targeting of C9ORF72 repeat RNA with fluorinated antisense oligonucleotides},
journal = {Nucleic Acids Research},
year = {2026},
volume = {54},
number = {8},
doi = {10.1093/nar/gkag343}
}
EUVIMED